
PEG-MGF
- 5mg
For laboratory research use only. Not for human or veterinary use. Not a medicine, food supplement or cosmetic.

Research use only. Not for human or veterinary use. Not a medicine, food supplement or cosmetic.
WADA notice. This compound is on the World Anti-Doping Agency Prohibited List. It is supplied for laboratory research and must not be used in sport.
Batch certificates are moving here from the old Quality Centre. To get the CoA for the batch you would receive today, email [email protected] with the SKU.
Follistatin-344 (FST-344) is a synthetic analog of the natural glycoprotein follistatin, engineered to mimic the 344-amino-acid isoform most abundantly expressed across tissues. It binds and neutralizes growth-inhibitory TGF-β family members—especially myostatin and activins—making it an essential tool in research settings focused on myostatin biology, tissue differentiation, and TGF-β signaling regulation. Supplied as a lyophilised powder for research use only, FST-344 is produced to high purity standards for reliable laboratory applications.
FST-344 acts as a natural antagonist to myostatin (GDF-8) and activins—key negative regulators of skeletal muscle mass and tissue differentiation in model systems. By blocking these ligands, it enables investigation into myocyte hypertrophy and cellular development in vitro.
In preclinical models, including mice and primates, FST-344 has been shown to promote muscle fiber growth, preserve muscle mass, and activate anabolic signaling (e.g., via Akt/mTOR)—making it a valuable candidate for studying muscle wasting and recovery mechanisms.
By neutralizing activin, FST-344 may facilitate tissue regeneration and reduce fibrosis. Animal studies indicate potential to limit liver fibrosis and enhance tissue repair pathways.
Emerging research in diabetes models suggests Fst overexpression may improve pancreatic β-cell mass, glucose regulation, and insulin-related pathways, indicating the peptide’s broader influence on metabolic research settings.
FST-344’s modulation of TGF-β ligand signaling may affect tumor cell behavior, including proliferation, metastasis, and drug resistance, making it relevant in emerging oncology-focused extracellular milieu studies.
Follistatin-344 is a versatile research-grade peptide for probing the roles of TGF-β regulators in myogenesis, tissue repair, metabolic regulation, and cancer biology. Supplied strictly for research use only, it is not intended for human or veterinary application.
• Synonyms: Follistatin-344; FST-344; Activin-binding protein
• Molecular Weight: ~3780 g/mol
• CAS Number: 53‑84‑9
• PubChem CID: 178101631
• Further References: PubChem Entry
• Stability: Stable for up to 36 months at –20 °C or lower, protected from light and moisture.
• Source: Synthesized via solid-phase peptide techniques; high-purity synthesis with Certificate of Analysis (COA) confirmation.
• Reconstitution: Reconstitute in sterile water or PBS under aseptic conditions; aliquot and store at –80 °C after reconstitution to preserve activity. Reconstitute with Bacteriostatic Water
• Usage: Product is prepared for LABORATORY RESEARCH ONLY.



IGF-1 LR3


